Want to track 0QBO and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 59 days
Summary
0QBO trading today lower at kr570.4, a decrease of 2.35% from yesterday's close, completing a monthly decrease of -3.06% or kr18. Over the past 12 months, 0QBO stock lost -27.9%.
0QBO is not paying dividends to its shareholders.
The last earnings report, released on Nov 04, 2025, missed the consensus estimates by -3.17%. On average, the company has fell short of earnings expectations by -0.27%, based on the last three reports. The next scheduled earnings report is due on Feb 02, 2026.
The stock of the company had never split.
The company's stock is traded on 9 different exchanges and in various currencies, with the primary listing on XWBO (EUR).
0QBO Chart
Coloplast A/S (0QBO) FAQ
What is the stock price today?
The current price is kr570.40.
On which exchange is it traded?
Coloplast A/S is listed on XWBO.
What is its stock symbol?
The ticker symbol is 0QBO.
Does it pay dividends? What is the current yield?
Yes, It pays dividends and the current yield is 20%.
What is its market cap?
As of today, no market cap data is available.
When is the next earnings date?
The next earnings report will release on Feb 02, 2026.
Has Coloplast A/S ever had a stock split?
No, there has never been a stock split.
Coloplast A/S Profile
| - Industry | - Sector | Mr. Kristian Villumsen CEO | LSE Exchange | DK0060448595 ISIN |
| Denmark Country | 16,639 Employees | 23 Aug 1970 Last Dividend | - Last Split | - IPO Date |
Overview
Founded in 1954 and based in Humlebæk, Denmark, Coloplast A/S is a leading developer and marketer of intimate healthcare products and services on a global scale. The company's offerings cater to a range of chronic care needs, with operations extending across markets like Denmark, the United States, the United Kingdom, France, and several other countries worldwide. It is organized into a series of divisions including Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Care, each dedicated to improving the quality of life for individuals facing various health challenges.
Products and Services
Coloplast A/S offers a diverse array of medical products and services designed to address specific healthcare needs:
- Ostomy Care Products: Notably, the SenSura Mio, tailored to fit individual body shapes for optimal discretion and comfort across different ostomy types. Additionally, the SenSura range and Brava accessories provide comprehensive ostomy care solutions.
- Continence Care Products: These include Conveen Active urine bags for active lifestyles, SpeediCath catheters that simplify catheterization for both men and women, and Peristeen Plus, an advanced transanal irrigation system.
- Wound Care Products: Offering Biatain Silicone, a conforming dressing, and Comfeel, a hydrocolloid dressing, along with a suite of skin care products ranging from cleansers and moisturizers to antifungal and protective solutions. InterDry stands out as a unique solution for managing skin folds.
- Interventional Urology Products: A line of products for surgical treatments addressing urinary stone diseases, benign prostate hyperplasia, voiding dysfunctions, erectile dysfunction, and urinary incontinence.
- Voice and Respiratory Care Solutions: The Provox system provides laryngectomy patients with voice prosthesis options for speaking, along with HMEs (Heat and Moisture Exchangers), adhesives, laryngectomy tubes, hands-free speaking devices, and other accessories. For tracheostomy care, Coloplast offers products under the Tracoe brand.
Contact Information
Address: Holtedam 1-3
Phone: 45 49 11 11 11
Website: https://www.coloplast.com
2025 © Marketlog. All Rights Reserved.
